Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 22
296
Views
7
CrossRef citations to date
0
Altmetric
Research Articles

Two new compounds with Nrf2 inducing activity from Glycyrrhiza uralensis

, , , , , , , & show all
Pages 4357-4364 | Received 08 Oct 2019, Accepted 04 Jan 2020, Published online: 30 Jan 2020
 

Abstract

Two new compounds including a new 3-arylcoumarin liquiritcoumarin (1), and a new flavonoid glycoside crotoliquiritin (2), together with twelve known compounds (314) were isolated from the radix and rhizome of Glycyrrhiza uralensis. Their structures were elucidated on the basis of extensive spectroscopic data analyses. All of the compounds were evaluated for the cytotoxic activities. Only compound 5 showed moderate effects with IC50 of 11.46 μM for A549 cells and IC50 of 7.38 μM for NCI-H292 cells. Compounds 1 and 2 were demonstrated to be Nrf2 pathway activators by using a stable antioxidant response element (ARE)-dependent reporter gene assay together with immunoblot and immunofluorescence analysis.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was financially supported by the National Natural Science Foundation of China (No. 81973202) and the Key Research and Development Program of Shandong Province (No. 2018GSF118085).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.